Autoimmune diseases affect roughly 15 million Americans, or about 4.6% of the U.S. population, based on a large analysis of electronic health records published in The Journal of Clinical Investigation. That number likely underestimates the true burden, since many autoimmune conditions take years to diagnose and some people never receive a formal diagnosis at all. Scientists currently recognize more than 80 distinct autoimmune diseases, and some estimates that account for undiagnosed cases place the total number of affected Americans between 24 and 50 million.
The Most Common Types
Not all autoimmune diseases are equally widespread. The five most prevalent conditions in the U.S. are rheumatoid arthritis, psoriasis, type 1 diabetes, Graves’ disease, and autoimmune thyroiditis (also called Hashimoto’s disease). The first two on that list, rheumatoid arthritis and psoriasis, account for a large share of all autoimmune diagnoses. Many of the remaining 80-plus conditions are individually rare but collectively add up to a significant number of people.
Some of these diseases overlap. It’s not unusual for someone diagnosed with one autoimmune condition to develop a second. A Norwegian study tracking children from birth found that among those who developed an autoimmune disease, about 5% received two or three distinct diagnoses by age 18. This clustering tendency holds in adults too, which is why doctors often screen for related conditions once one is identified.
Women Are Disproportionately Affected
The most striking demographic pattern in autoimmune disease is the gap between women and men. As many as 4 out of 5 people with an autoimmune condition are women. For some diseases the imbalance is extreme: lupus affects women at a ratio of 9 to 1 compared to men. Thyroid-related autoimmune diseases also skew heavily female.
Researchers at Stanford have linked this disparity to a molecular process involving the X chromosome. Because women carry two X chromosomes, one copy in each cell gets silenced during development. That silencing process can sometimes trigger the immune system to produce antibodies against the body’s own tissues. This mechanism helps explain why the female-to-male gap is so consistent across dozens of different autoimmune conditions, even though those conditions affect entirely different organs.
When Autoimmune Diseases Typically Appear
Most autoimmune diseases strike younger and middle-aged adults, often between the ages of 20 and 50. That distinguishes them from many chronic illnesses that cluster in older populations. Some conditions have even earlier windows. Type 1 diabetes frequently appears in childhood or adolescence, and juvenile idiopathic arthritis and juvenile dermatomyositis are, as their names suggest, childhood-onset diseases.
In children specifically, autoimmune conditions are not as rare as many parents assume. The Norwegian population study found an overall incidence rate of about 163 per 100,000 children per year across six common autoimmune diseases, including type 1 diabetes, celiac disease, inflammatory bowel disease, and juvenile arthritis. That translates to roughly 1 in every 600 children developing one of these conditions in a given year.
Rates Are Climbing
Autoimmune diseases are becoming more common over time, not just because of better detection. Data from the Global Burden of Disease Study, which tracks health trends across countries from 1990 to 2021, shows meaningful increases in several conditions. Rheumatoid arthritis incidence rose by about 0.75% per year over that period, and type 1 diabetes climbed at a similar pace. Psoriasis showed smaller but consistent increases. Inflammatory bowel disease rose only modestly, and multiple sclerosis remained relatively stable.
The reasons behind the overall upward trend are still debated, but the leading explanations point to environmental and lifestyle changes rather than genetics, which don’t shift this quickly at a population level. Factors under investigation include changes in diet, increased antibiotic use disrupting gut bacteria, reduced childhood exposure to infections (sometimes called the hygiene hypothesis), and rising rates of obesity. The increases are most pronounced in industrialized countries and in nations that have recently undergone rapid economic development, which supports the idea that something about modern environments is pushing immune systems toward self-attack.
The Financial Weight of Autoimmune Disease
Because autoimmune diseases are chronic, often requiring lifelong treatment, their economic impact is substantial. Estimating a single total cost is difficult because each condition has been studied separately using different methods. What is clear from the available data is that even relatively uncommon autoimmune conditions carry outsized costs. Alopecia areata, a condition that causes hair loss and is sometimes perceived as cosmetically minor, generates nearly $907 million in annual costs in the U.S. Chronic inflammatory demyelinating polyneuropathy, a rare nerve condition, costs over $330 million annually despite affecting a small number of people.
For patients, the financial burden often goes beyond medical bills. Many autoimmune diseases cause fatigue, pain, and unpredictable flare-ups that reduce the ability to work. The combination of high treatment costs and lost productivity makes autoimmune disease one of the more expensive categories of chronic illness per person, even though individual conditions may fly under the radar compared to heart disease or cancer.
Why the Numbers Are Hard to Pin Down
You’ll notice a wide range in the estimates cited for autoimmune disease prevalence. The 15 million figure from electronic health records captures only people who received a formal diagnosis code in a medical system. The higher estimates, reaching up to 50 million, attempt to account for people who haven’t been diagnosed yet or whose conditions were coded differently. The gap between these numbers reflects a real problem: autoimmune diseases are notoriously slow to diagnose. Many patients see multiple doctors over several years before getting an answer, and some conditions, like celiac disease, can be present for a decade before symptoms become obvious enough to prompt testing.
The actual number of Americans living with at least one autoimmune condition almost certainly falls somewhere between those bounds. What’s not in dispute is that these diseases, taken together, affect more people than cancer or heart disease, and that the numbers are growing.